Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 1CNS 1

Conditions

Neurofibromatosis 1 1Neurofibromatoses 1Neoplasm Metastasis 1Melanoma 1

Interventions

Paclitaxel 292Gemcitabine 254Carboplatin 254Cisplatin 251Radiotherapy 219Cyclophosphamide 218Irinotecan 184pembrolizumab 181Docetaxel 174Bevacizumab 166Capecitabine 148Nivolumab 141Fluorouracil 132Dexamethasone 125Bortezomib 123Oxaliplatin 115Cytarabine 113Erlotinib Hydrochloride 112Temozolomide 110Sorafenib 110Doxorubicin 106Rituximab 105Leucovorin 105Etoposide 105Filgrastim 99Everolimus 97Lenalidomide 95Pemetrexed 90Ipilimumab 90fludarabine phosphate 84

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Completed × diphenylcyclopropenone × Clear all
NCT05438290 2024-05-06

DPCP to Treat Cutaneous Neurofibromas Associated With NF1

Icahn School of Medicine at Mount Sinai

Phase 1 Completed
17 enrolled
CNS

Neurofibromatosis 1, Neurofibromatoses

NCT01711684 2017-11-29

Treatment of Cutaneous Metastases With Diphenylcyclopropenone (DPCP)

Rockefeller University

Phase 1 Completed
6 enrolled
Dermatologic

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡